Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lupin Buys Stake In South Africa’s Pharma Dynamics; Aims To Be In Top 3  

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - After months of negotiations, Indian generic drug maker Lupin acquired a 60 percent equity stake in South Africa's sixth largest generic drug maker Pharma Dynamics with the goal of joining the top ranks of companies in South Africa in three years
Advertisement

Related Content

India’s Lupin Set For Global Generics Growth; Logs 53 Percent Profit Jump In Q2
India’s Lupin Set For Global Generics Growth; Logs 53 Percent Profit Jump In Q2
Ranbaxy Disappointed By U.S. FDA’s Warning Letters And “Import Alert”
Lupin Deal Spree Continues, Looks ‘Down Under’ For Generic Growth
Lupin Deal Spree Continues, Looks ‘Down Under’ For Generic Growth
Advertisement
UsernamePublicRestriction

Register

SC069604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel